Huijing Acne Treatment Pads Recall: Subpotent Drug Risk
Huijing recalls 50-count acne pads with 2% salicylic acid due to subpotent drug levels. Product may not deliver intended treatment. Check NDC 71537-0:001-02 and lot #2458067.
Lower-risk recall
Subpotent drug: The product active ingredient level not matching the exact levels indicated on the packaging label.
Contact the company
What happened, in plain English
Huijing recalls acne treatment pads that may not contain enough salicylic acid to treat acne as labeled. This means the product might not work as intended for users. Read more at govinfonow.com/recall/39789-huijing-acne-treatment-pads-recall-subpotent-drug-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/39789-huijing-acne-treatment-pads-recall-subpotent-drug-risk · Updated October 6, 2026 · FDA enforcement record: FDA #D-1076-2018
Cite this page
“Huijing Acne Treatment Pads Recall: Subpotent Drug Risk.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39789-huijing-acne-treatment-pads-recall-subpotent-drug-risk. Based on FDA recall #D-1076-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1076-2018%22&limit=1).
Why it’s dangerous
The product's active ingredient level is lower than what's listed on the label. This means the pads might not treat acne effectively, but it doesn't cause injury or harm.
Who’s affected
People who bought the 50-count acne pads with NDC 71537-001-02 and lot #2458067 from Greenbrier International. Those using the product for acne treatment are most at risk.
How to tell if you have this one
Check for the 50-count jar with NDC 71537-001-02 and lot number 2458067. The product was sold by Greenbrier International, Inc. in Chesapeake, VA.
- Brand
Huijing- Category
Drug
What to do — step by step
Check Product Details
Look for NDC 71537-001-02 and lot #2458067 on the packaging.
Where it went and when
Where it was distributed
Distributed in Virginia.
FDA distribution: “Product was distributed to one distributor in VA” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Virginia.
Recall timeline
FDA terminated this recall 5 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
What should I do with the product?
The recall does not require immediate action; check the product details and consider using it if it works for you.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1076-2018 (August 3, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1076-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.